Ablitech receives more ‘Seed’ money from MTA
RIDGELAND and HATTIESBURG — Mississippi Technology Alliance (MTA) president and CEO Tony Jeff announced that Ablitech Inc., a biotechnology company based in Hattiesburg, has received a second round Research and Development investment from the Mississippi Seed Fund.
Ridgeland-based MTA invested $100,000 in Ablitech for further product and market development of Versadel, the company’s proprietary gene therapeutic delivery technology.
Ablitech received a first-round investment of $100,000 from the Seed Fund in Sept. 2009. The company achieved all goals and milestones in their first round of funding, which made them eligible for second round funding.
“MTA’s investment helps move our technology for delivering gene therapeutics from the laboratory to the marketplace,” said Ken Malone, co-founder and CEO of Ablitech.
The Mississippi Seed Fund was established by the Mississippi Legislature to provide start-up technology companies with access to pre-seed financing, early stage risk capital and product development capital to accelerate the development of high-performance, innovation-based business ventures in Mississippi. The fund is managed by the MTA.
Recipients must have a cash match from accredited investors to obtain funding.
To sign up for Mississippi Business Daily Updates, click here.
FOLLOW THE MBJ ON TWITTERMy Tweets
Top Posts & Pages
- Mad Genius, Eyevox owner acquires Mississippi Film Studios
- Payday lender, fired executive exchanging blame for lender’s regulatory woes
- UPDATE — David Watkins says JRA left him in dark about HUD's Farish St. involvement
- UMMC reaching out after death of high school football player
- Grain buyer’s bankruptcy could take steep toll on Delta farmers
- Report: Mississippi has worst child poverty rate in U.S.
- UPDATED: Jackson agrees to repay HUD $1.5 million for Farish Street blunders
- Fitch gives Mississippi Power a negative outlook due to Kemper plant
- Nehi Bottling Company has been a Cleveland fixture for 85 years